Table 2—

Patients with epidermal growth factor receptor mutations

Patient No.Age yrsSexMutation exonSampling techniqueStage
162Male21 (Leu858Arg)SurgeryIV
247Female21 (Leu858Arg)PericardiocentesisIV
369Male19 (745−750del)EBUS-TBNAIV
470Female21 (Leu858Arg)SurgeryIIIA
571Male19 (751−759del)EBUS-TBNAIV
  • In all cases, the patients exhibited an adenocarcinoma pathology. Leu858Arg: substitution of leucine 858 with arginine; del: deletion of codon numbers indicated; EBUS-TBNA: endobronchial ultrasound-guided transbronchial needle aspiration.